BELITE BIO, INC (BLTE) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$84.21M | -110.5% |
| 2024 | -$40.00M | -26.3% |
| 2023 | -$31.67M | -147.0% |
| 2022 | -$12.82M | -30.9% |
| 2021 | -$9.80M | -70.6% |
| 2020 | -$5.74M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$84.21M | -110.5% |
| 2024 | -$40.00M | -26.3% |
| 2023 | -$31.67M | -147.0% |
| 2022 | -$12.82M | -30.9% |
| 2021 | -$9.80M | -70.6% |
| 2020 | -$5.74M | — |